India's Venus Remedies up on Saudi marketing approval for syringes

Venus Remedies

28/08/2023 08:08

** Shares of Venus Remedies  VENR.NS  up as much as 4.57% to
243.85 rupees
    ** Research and pharmaceutical firm said it recieved
marketing approval from Saudi Arabia for Enoxaparin Pre-filled
syringes (PFS) 
    ** Enoxaparin PFS is used to address blood clot formation in
thrombosis and other cardiovascular diseases
    ** About 21,581 shares change hands as of 12:29 p.m. IST,
0.8x 30-day average 
    ** Stock up 28.8% YTD as of last close

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))